Danazol therapy for thrombocytopenia in patients with myelodysplastic syndromes.
Viniou
Nora
N
First Department of Internal Medicine, University of Athens School of Medicine, Laikon General Hospital, Athens, Greece. jbnv@otenet.gr
Plata
Eleni
E
Terpos
Evangelos
E
Variami
Eleni
E
Meletis
John
J
Vaiopoulos
George
G
Loukopoulos
Dimitris
D
Chatzidimitriou
Georgia
G
Yataganas
Xenophon
X
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003613:Danazol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications*; D010976:Platelet Count; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D003613:Danazol